Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/23/2003US20030199056 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199052 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199051 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199044 IL-17 homologous polypeptides and therapeutic uses thereof
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030199042 Novel morphogenic protein
10/23/2003US20030199040 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18
10/23/2003US20030199033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199032 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199031 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199030 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199029 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199028 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199027 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199026 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199025 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199023 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199020 Chimeric heteromultimer adhesins
10/23/2003US20030199013 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
10/23/2003US20030199009 Modifications of apoptin
10/23/2003US20030199008 Nucleic Acids, Proteins, and antibodies
10/23/2003US20030199007 Are unique to diseased states, particularly tumors and blood-borne malignancies; useful for therapeutic purposes
10/23/2003US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA
10/23/2003US20030198993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198976 Identifying agonists and antagonists of the polynucleotides and polypeptides of the receptor; diagnosis, treatment, and/or prevention of various diseases and/ or disorders related to these polypeptides
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198965 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
10/23/2003US20030198958 Noval human proteins, polynucleotides encoding them and methods of using the same
10/23/2003US20030198957 Proteins and nucleic acids encoding same
10/23/2003US20030198955 Novel proteins and nucleic acids encoding same
10/23/2003US20030198954 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198951 Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198691 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
10/23/2003US20030198687 Contacting with activated blood platelets; wound healing agents
10/23/2003US20030198680 Solid, free-flowing powder; solid hydrophobic nanostructure; moisture trigger release
10/23/2003US20030198674 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
10/23/2003US20030198666 Side effect reduction; using mixture of insulin and adjuvant
10/23/2003US20030198657 Mixture with retinoid and perilla oil
10/23/2003US20030198652 Multi component controlled release system for anhydrous cosmetic compositons
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198646 Sealed tube containing papilla cells; induction hair growth
10/23/2003US20030198643 Adjuvant enhanced immunotherapy
10/23/2003US20030198641 Immunoassay, immunotherapy; antiinflammatory agents; anticancer agents
10/23/2003US20030198640 Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
10/23/2003US20030198636 Prevent completitive binding; amplification inflammation response; convertase inhibitor; side effect reduction
10/23/2003US20030198635 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
10/23/2003US20030198634 Methods of treating joint inflammation with chimeric anti-TNF antibodies
10/23/2003US20030198632 Thermolysin enzymatic wound debrider
10/23/2003US20030198631 Thermolysin enzymatic wound debrider
10/23/2003US20030198624 Cytokine gene expression therapy; antiinflammatory agnets, respiratory system disorders
10/23/2003US20030198623 Attenuation Dna; coding cytokines, tumor antigen
10/23/2003US20030198622 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198620 Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
10/23/2003US20030198619 Mixture containing permeability intensifier; in situ gelation using nonionic surfactant
10/23/2003US20030198618 T1 receptor-like ligand II and uses thereof
10/23/2003US20030198617 Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
10/23/2003US20030198611 Method of treating onychomycosis with urea and an antioxidant
10/23/2003US20030198602 Improved absorption; drug delivery
10/23/2003US20030198601 Dry powder drug; aerosol administering
10/23/2003US20030198596 Genetic engineered plasmids; diagnosis glandular disorders
10/23/2003CA2482926A1 Modified factor viii
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482893A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482612A1 Use of substances for treatment of tumors
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482263A1 Therapeutic dry powder preparation
10/23/2003CA2482262A1 Tissue defect dressings comprising a keratin network
10/23/2003CA2482215A1 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them
10/23/2003CA2481958A1 Anti-inflammatory and wound healing effects of lymphoid thymosin .beta.-4
10/23/2003CA2481784A1 Methods for lightening skin and hair
10/23/2003CA2481752A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481344A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003CA2481339A1 Methods for targeting quadruplex dna
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481239A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
10/23/2003CA2481231A1 Colon tumor specific binding peptides
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2480883A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003CA2480858A1 Treatment of gastroparesis
10/23/2003CA2480809A1 Methods for inhibiting vascular hyperpermeability
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480671A1 C-jun phosphorylation inhibitors
1 ... 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 ... 3163